Company news
NeuroOne Medical Technologies Corporation news in 2021
NeuroOne Medical Technologies Corporation's news releases, calls and decks from 2021, newest first.
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate Update
December 14, 2021
NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode
September 22, 2021
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
September 6, 2021
NeuroOne Announces Strategic Partnership with RBC Medical Innovations for Ablation Program
August 22, 2021
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate Update
August 12, 2021
NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity
June 1, 2021
NeuroOne Announces Approval for Nasdaq Capital Market Listing; Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTC
May 24, 2021
NeuroOne Medical Technologies Corporation Announces Reverse Stock Split as Part of Uplisting Strategy to Major Exchange
March 30, 2021
NeuroOne Medical Technologies Corporation Announces Successful Completion of First Performance Milestone in Zimmer Biomet Agreement
February 22, 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
January 14, 2021
NeuroOne Medical Technologies Corporation Announces Private Placement
January 11, 2021
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
January 6, 2021